Reuters logo
Allergan says exploring sale of obesity business
October 30, 2012 / 3:15 PM / 5 years ago

Allergan says exploring sale of obesity business

Oct 30 (Reuters) - Allergan Inc said it was exploring a sale of its obesity business on falling sales of the only product in the unit.

Sales of Lap-Band fell 21 percent to $122.7 million, while sales of most of Allergan’s products increased during the third quarter.

The unit accounted for about 4 percent of Allergan’s total revenue in 2011.

The company expects sales of $160 million from its obesity intervention products unit for the full year. It sees total product net sales of between $5.69 billion and $5.77 billion.

U.S. health regulators recently approved two weight loss drugs, after a gap of 13 years, underlining the mounting pressure on the Food and Drug Administration to approve treatments for obesity as about two-thirds of Americans are considered overweight or obese.

Lap-Band, which was first approved by the FDA in 2001, has an inflatable band placed around the stomach through a minimally invasive surgery, creating a pouch that limits or reduces food consumption.

The company posted a profit of $249.4 million, or 82 cents per share, in the third quarter compared with $249.8 million, or 81 cents per share, a year earlier.

Adjusting for charges that include restructuring, research and development, and amortization of acquired intangible assets, the company earned $1.06 per share.

Revenue rose 6 percent to $1.4 billion.

Analysts were expecting a profit of $1.04 per share, excluding special items, on revenue of $1.43 billion, according to Thomson Reuters I/B/E/S.

Shares of the Irvine, California-based company, which has a market capitalization of $21.18 billion dollars, closed at $91.64 on Friday on the New York Stock Exchange.

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below